GSK set a challenge to researchers around the world to develop an implantable device that can record, stimulate and/or block the activation of visceral nerves. The first team that demonstrates a working prototype wins a $1m prize. A competitive application process resulted in funding for 10 teams: the Bionics Institute is part of a successful Australian application led by the Sydney engineering group EC and Associates, and in collaboration with the University of Melbourne.
The challenge is to produce a small, wireless implantable device that modulates the activity of nerves to restore healthy function to visceral organs, such as the bladder. Read more on the GSK website and blog.